Comparative safety and effectiveness of low-molecular-weight heparin, direct thrombin inhibitors, and factor Xa inhibitors for venous thromboembolism prophylaxis among patients with blunt trauma: a retrospective cohort study

Venous thromboembolism (VTE) is a leading cause of preventable mortality among patients with trauma. Although low-molecular-weight heparin (LMWH) is the standard prophylactic agent, direct thrombin inhibitors (DTIs) and factor Xa inhibitors (FXaIs) offer potential alternatives. However, their comparative efficacy and safety among patients with blunt trauma remain unclear. This study aimed to compare the efficacy and safety​ of DTIs and FXaIs, using LMWH as the reference for VTE prophylaxis. This retrospective cohort study was conducted using the American College of Surgeons Trauma Quality Improvement Program database between 2020 and 2022. Patients with blunt trauma and an Injury Severity Score ≥ 10 who received LMWH, DTIs, or FXaIs for VTE prophylaxis were included. Efficacy outcomes included deep vein thrombosis (DVT) and pulmonary embolism (PE). Safety outcomes evaluated were unplanned return to the operating room and in-hospital mortality. Multivariable logistic regression and 20:1 propensity score matching (PSM) adjusting for demographics, injury severity, comorbidities, and prophylaxis timing were performed to reduce potential confounding. Among 307,638 eligible patients, 305,049 received LMWH, 342 received DTIs, and 2247 received FXaIs. Compared to LMWH, DTIs were associated with significantly higher odds of DVT (odds ratio [OR] 3.62; 95% confidence interval [CI] 2.25–5.84), PE (OR 3.46; 95% CI 1.75–6.82), unplanned return to the operating room​ (OR 2.08; 95% CI 1.22–3.54), and mortality (OR 1.70; 95% CI 1.10–2.64). FXaIs also increased the odds of DVT (OR 2.79; 95% CI 2.19–3.56) and PE (OR 3.40; 95% CI 2.53–4.57) compared to LMWH; however, no significant difference was observed in unplanned return to the operating room​ (OR 0.74; 95% CI 0.50–1.09) or mortality (OR 1.06; 95% CI 0.83–1.36). Consistent findings were confirmed in the PSM cohort, where DTI retained significantly increased odds of VTE and unplanned return to the operating room​, while FXaIs showed comparable safety profiles to LMWH. LMWH was associated with lower odds of VTE than DTIs and FXaIs, and DTIs were additionally associated with higher odds of unplanned return to the operating room. FXaIs showed safety outcomes comparable to LMWH and may be considered when LMWH cannot be used. Further prospective studies are needed to guide agent selection in specific clinical scenarios.

Authors

Institutions

Publication Details

Journal
BMC Surgery
Published
2026-11-16
DOI
https://doi.org/10.1186/s12893-026-04357-2
Primary Topic
Venous Thromboembolism Diagnosis and Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Comparative safety and effectiveness of low-molecular-weight heparin, direct thrombin inhibitors, and factor Xa inhibitors for venous thromboembolism prophylaxis among patients with blunt trauma: a retrospective cohort study

Hsu Chih-Po, Shu‐Yi Huang, Chia-Hsiang Hu, Hsuan-Fan Tung et al.
1 links
BMC Surgery
Venous Thromboembolism Diagnosis and Management
article

Comparative safety and effectiveness of low-molecular-weight heparin, direct thrombin inhibitors, and factor Xa inhibitors for venous thromboembolism prophylaxis among patients with blunt trauma: a retrospective cohort study

Hsu Chih-Po, Shu‐Yi Huang, Chia-Hsiang Hu, Hsuan-Fan Tung, Jhih-Ming Tang, Jen-Fu Huang, Shion-Wei Chai, Chi-Tung Cheng, Chien-Hung Liao
article en

Abstract

Venous thromboembolism (VTE) is a leading cause of preventable mortality among patients with trauma. Although low-molecular-weight heparin (LMWH) is the standard prophylactic agent, direct thrombin inhibitors (DTIs) and factor Xa inhibitors (FXaIs) offer potential alternatives. However, their comparative efficacy and safety among patients with blunt trauma remain unclear. This study aimed to compare the efficacy and safety​ of DTIs and FXaIs, using LMWH as the reference for VTE prophylaxis. This retrospective cohort study was conducted using the American College of Surgeons Trauma Quality Improvement Program database between 2020 and 2022. Patients with blunt trauma and an Injury Severity Score ≥ 10 who received LMWH, DTIs, or FXaIs for VTE prophylaxis were included. Efficacy outcomes included deep vein thrombosis (DVT) and pulmonary embolism (PE). Safety outcomes evaluated were unplanned return to the operating room and in-hospital mortality. Multivariable logistic regression and 20:1 propensity score matching (PSM) adjusting for demographics, injury severity, comorbidities, and prophylaxis timing were performed to reduce potential confounding. Among 307,638 eligible patients, 305,049 received LMWH, 342 received DTIs, and 2247 received FXaIs. Compared to LMWH, DTIs were associated with significantly higher odds of DVT (odds ratio [OR] 3.62; 95% confidence interval [CI] 2.25–5.84), PE (OR 3.46; 95% CI 1.75–6.82), unplanned return to the operating room​ (OR 2.08; 95% CI 1.22–3.54), and mortality (OR 1.70; 95% CI 1.10–2.64). FXaIs also increased the odds of DVT (OR 2.79; 95% CI 2.19–3.56) and PE (OR 3.40; 95% CI 2.53–4.57) compared to LMWH; however, no significant difference was observed in unplanned return to the operating room​ (OR 0.74; 95% CI 0.50–1.09) or mortality (OR 1.06; 95% CI 0.83–1.36). Consistent findings were confirmed in the PSM cohort, where DTI retained significantly increased odds of VTE and unplanned return to the operating room​, while FXaIs showed comparable safety profiles to LMWH. LMWH was associated with lower odds of VTE than DTIs and FXaIs, and DTIs were additionally associated with higher odds of unplanned return to the operating room. FXaIs showed safety outcomes comparable to LMWH and may be considered when LMWH cannot be used. Further prospective studies are needed to guide agent selection in specific clinical scenarios.

BMC Surgery
Chang Gung University (TW), Jen-Ai Hospital (TW), Far Eastern Memorial Hospital (TW), Linkou Chang Gung Memorial Hospital (TW)
Good health and well-being
Venous Thromboembolism Diagnosis and Management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon